Mei-Yu Lv

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0001-6448-0128

发表论文 23 篇 · 总被引 418 次 · h-index 11

代表论文

• In vivo assembly enhanced binding effect augments tumor specific ferroptosis therapy (2024 · Nature Communications · 被引 95)
• Machine-Learning Algorithm-Based Prediction of Diagnostic Gene Biomarkers Related to Immune Infiltration in Patients With Chronic Obstructive Pulmonary Disease (2022 · Frontiers in Immunology · 被引 56)
• A Lysosome-Targeting Self-Condensation Prodrug-Nanoplatform System for Addressing Drug Resistance of Cancer (2022 · Nano Letters · 被引 39)
• Complex Evaluation of Surfactant Protein A and D as Biomarkers for the Severity of COPD (2022 · International Journal of COPD · 被引 31)
• Cascade-Activatable Nanoprodrug System Augments Sonochemotherapy of Bladder Cancer (2024 · ACS Nano · 被引 28)
• In vivo self-assembled bispecific fluorescence probe for early detection of bladder cancer and metastasis (2024 · 中国科学通报：英文版 · 被引 23)